New Jersey A2444 mandates the Department of Health to study racial disparities in ovarian cancer.
New Jersey A2444 requires the Department of Health to conduct a study on the racial aspects of ovarian cancer. The study aims to identify differences in effects, rates, risk factors, symptoms, and outcomes among women from various racial and ethnic groups, including Asian, African-American, Caucasian, Hispanic, Native American, and Pacific Islander. Within one year of the bill's enactment, the Department of Health must submit a report of the study's findings to the Governor and the Legislature. The bill takes effect immediately and expires upon the report's submission.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.